(2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R)-6-hydroxy-3,4,5-tris[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Term ID

CHEBI:152061

Synonyms

beta-D-galacto-hexopyranosyl-(1->2)-[beta-D-galacto-hexopyranosyl-(1->3)][beta-D-galacto-hexopyranosyl-(1->4)][beta-D-galacto-hexopyranosyl-(1->6)]-D-gluco-hexopyranose
Gal(b1-2)[Gal(b1-3)][Gal(b1-4)][Gal(b1-6)]Glc
WURCS=2.0/2,5,4/[a2122h-1x_1-5][a2112h-1b_1-5]/1-2-2-2-2/a2-b1_a3-c1_a4-d1_a6-e1

Definition

References

GlyGen:G56978EC
GlyTouCan:G56978EC

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R)-6-hydroxy-3,4,5-tris[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype where environments contain (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R)-6-hydroxy-3,4,5-tris[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R)-6-hydroxy-3,4,5-tris[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype affecting (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5R)-6-hydroxy-3,4,5-tris[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]oxane-3,4,5-triol

Human Disease Model